Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Last year, legislation calling for a Prescription Drug Affordability Board cleared the General Assembly but was vetoed by Gov ...

Legislators plan a confrontation with Gov. Glenn Youngkin over two of his highest-profile vetoes last year: bills for a state ...

Healey plans to host a ceremony at 11 a.m. Wednesday with legislative leaders to sign both the prescription drug bill and a ...